Table 2 Impact of donor and supplementation of celecoxib (CX) or vehicle (PEG) on bacterial community metrics at (A) the beginning of the incubation (0 h, n = 6) and (B) once the incubation was finalized (16 h, n = 8).

Metric	Index	Treatment		SEM	P value of each effect
Metric	Index	CX	PEG	SEM	Treatment	Donor	Treatment*Donor interaction
(A)
Evenness	Pielou	0.61	0.60	0.0009	0.83	0.0001	0.23
Alpha diversity	Shannon (H’)	2.71	2.72	0.03	0.81	<0.0001	0.13
	Simpson	0.85	0.85	0.007	0.43	<0.0001	0.04
	Inverse Simpson (D₂)	8.00	8.48	0.53	0.54	<0.0001	0.76
	Fisher’s diversity	13.41	13.16	0.25	0.49	<0.0001	0.34
Richness	Total richness (S)	92.50	95.83	3.83	0.55	0.002	0.77
Abundance	Chao	144.12	128.55	9.54	0.27	0.01	0.59
(B)
Evenness	Pielou	0.55	0.59	0.01	0.06	0.003	0.38
Alpha diversity	Shannon (H’)	2.54	2.70	0.06	0.08	0.001	0.33
	Simpson	0.84	0.86	0.009	0.14	0.009	0.10
	Inverse Simpson (D₂)	7.59	8.13	0.63	0.55	0.02	0.23
	Fisher’s diversity	13.28	13.17	0.25	0.49	<0.0001	0.34
Richness	Total richness (S)	92.56	97.12	2.78	0.88	0.005	0.07
Abundance	Chao	94.01	114.65	5.34	0.01	0.008	0.89

Quick links

Search